Mitochondrial abnormalities in the myofibrillar myopathies

European Journal of Neurology

Volumn 22, Issue 11, 2015, Pages 1429-1435

  Jackson, S ^a   Schaefer, J ^a   Meinhardt, M ^a   Reichmann, H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Mitochondria; Myofibrillar; Myopathies; Z disc

Indexed keywords

DESMINOPATHY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FILAMINOPATHY; GENE IDENTIFICATION; GENE MUTATION; HUMAN; IN VITRO STUDY; MITOCHONDRIAL ABNORMALITY; MITOCHONDRIAL MYOPATHY; MYOFIBRILLAR MYOPATHY; MYOPATHY; MYOTILINOPATHY; PLECTINOPATHY; PRIORITY JOURNAL; REVIEW; TITINOPATHY; ZASPOPATHY; CLASSIFICATION; GENETICS; MITOCHONDRION; PATHOLOGY;

HUMANS; MITOCHONDRIA; MYOPATHIES, STRUCTURAL, CONGENITAL;

EID: 84943356205     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12814     Document Type: Review

References (75)

1. Luther PK. The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling. J Muscle Res Cell Motil 2009; 30: 171-185.
2. Frank D, Kuhn C, Katus HA, Frey N. The sarcomeric Z-disc: a nodal point in signalling and disease. J Mol Med (Berl) 2006; 84: 446-468.
3. Picard M, White K, Turnbull DM. Mitochondrial morphology, topology, and membrane interactions in skeletal muscle: a quantitative three-dimensional electron microscopy study. J Appl Physiol (1985) 2013; 114: 161-171.
4. Capetanaki Y, Bloch RJ, Kouloumenta A, et al. Muscle intermediate filaments and their links to membranes and membranous organelles. Exp Cell Res 2007; 313: 2063-2076.
5. Winter L, Kuznetsov AV, Grimm M, et al. Plectin isoform P1b and P1d deficiencies differentially affect mitochondrial morphology and function in skeletal muscle. Hum Mol Genet 2015; pii: ddv184. doi:10.1093/hmg/ddv184.
6. Milner DJ, Mavroidis M, Weisleder N, et al. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 2000; 150: 1283-1298.
7. Schröder R, Schoser B. Myofibrillar myopathies: a clinical and myopathological guide. Brain Pathol 2009; 19: 483-492.
8. Selcen D. Myofibrillar myopathies. Neuromuscul Disord 2011; 21: 161-171.
9. Olivé M, Kley RA, Goldfarb LG. Myofibrillar myopathies: new developments. Curr Opin Neurol 2013; 26: 527-535.
10. Reimann J, Kunz WS, Vielhaber S, et al. Mitochondrial dysfunction in myofibrillar myopathy. Neuropathol Appl Neurobiol 2003; 29: 45-51.
11. Claeys KG, Fardeau M, Schröder R, et al. Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene. Neuromuscul Disord 2008; 18: 656-666.
12. Olivé M, Odgerel Z, Martínez A, et al. Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 2011; 21: 533-542.
13. Vattemi G, Neri M, Piffer S, et al. Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. Acta Myol 2011; 30: 121-126.
14. Katsetos CD, Koutzaki S, Melvin JJ. Mitochondrial dysfunction in neuromuscular disorders. Semin Pediatr Neurol 2013; 20: 202-215.
15. Knöll R, Buyandelger B, Lab M. The sarcomeric Z-disc and Z-discopathies. J Biomed Biotechnol 2011; 2011: 569628.
16. Kötter S1, Unger A, Hamdani N, et al. Human myocytes are protected from titin aggregation-induced stiffening by small heat shock proteins. J Cell Biol 2014; 204: 187-202.
17. Vicart P, Caron A, Guicheney P, et al. A missense mutation in the alphaBcrystallin chaperone gene causes a desmin-related myopathy. Nat Genet 1998; 20: 92-95.
18. Reilich P, Schoser B, Schramm N, et al. The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy. Neuromuscul Disord 2010; 20: 255-259.
19. Sacconi S, Féasson L, Antoine JC. A novel CRYAB mutation resulting in multisystemic disease. Neuromuscul Disord 2012; 22: 66-72.
20. Forrest KM, Al-Sarraj S, Sewry C, et al. Infantile onset myofibrillar myopathy due to recessive CRYAB mutations. Neuromuscul Disord 2011; 21: 37-40.
21. Selcen D, Muntoni F, Burton BK, et al. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 2009; 65: 83-89.
22. Odgerel Z, Sarkozy A, Lee HS, et al. Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation. Neuromuscul Disord 2010; 20: 438-442.
23. Semmler AL, Sacconi S, Bach J, et al. Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies. Orphanet J Rare Dis 2014; 9: 121.
24. Jaffer F, Murphy SM, Scoto M, et al. BAG3 mutations: another cause of giant axonal neuropathy. J Peripher Nerv Syst 2012; 17: 210-216.
25. Konersman CG, Bordini BJ, Scharer G, et al. BAG3 myofibrillar myopathy presenting with cardiomyopathy. Neuromuscul Disord 2015; 25: 418-422.
26. Clemen CS, Herrmann H, Strelkov SV, et al. Desminopathies: pathology and mechanisms. Acta Neuropathol 2013; 125: 47-75.
27. Schröder R, Goudeau B, Simon MC, et al. On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum Mol Genet 2003; 12: 657-669.
28. Fidziańska A, Kotowicz J, Sadowska M, et al. A novel desmin R355P mutation causes cardiac and skeletal myopathy. Neuromuscul Disord 2005; 15: 525-531.
29. Vernengo L, Chourbagi O, Panuncio A, et al. Desmin myopathy with severe cardiomyopathy in a Uruguayan family due to a codon deletion in a new location within the desmin 1A rod domain. Neuromuscul Disord 2010; 20: 178-218.
30. Hong D, Wang Z, Zhang W, et al. A series of Chinese patients with desminopathy associated with six novel and one reported mutations in the desmin gene. Neuropathol Appl Neurobiol 2011; 37: 257-270.
31. Henderson M, De Waele L, Hudson J, et al. Recessive desmin-null muscular dystrophy with central nuclei and mitochondrial abnormalities. Acta Neuropathol 2013; 125: 917-919.
32. Weihl CC, Iyadurai S, Baloh RH, et al. Autophagic vacuolar pathology in desminopathies. Neuromuscul Disord 2015; 2: 199-206.
33. McLaughlin HM, Kelly MA, Hawley PP, et al. Compound heterozygosity of predicted loss-of-function DES variants in a family with recessive desminopathy. BMC Med Genet 2013; 14: 68.
34. Sarparanta J, Jonson PH, Golzio C, et al. Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy. Nat Genet 2012; 44: 450-455.
35. Harms MB, Sommerville RB, Allred P, et al. Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy. Ann Neurol 2012; 71: 407-416.
36. Sato T, Hayashi YK, Oya Y, et al. DNAJB6 myopathy in an Asian cohort and cytoplasmic/nuclear inclusions. Neuromuscul Disord 2013; 23: 269-276.
37. Suarez-Cedeno G, Winder T, Milone M. DNAJB6 myopathy: a vacuolar myopathy with childhood onset. Muscle Nerve 2014; 49: 607-610.
38. Bertrand AT, Bonnemann CG, Bonne G. 199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands. Neuromuscul Disord 2014; 24: 453-462.
39. Windpassinger C, Schoser B, Straub V, et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008; 82: 88-99.
40. Schessl J, Taratuto AL, Sewry C, et al. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain 2009; 132: 452-464.
41. Schoser B, Goebel HH, Janisch I, et al. Consequences of mutations within the C terminus of the FHL1 gene. Neurology 2009; 73: 543-551.
42. Chen DH, Raskind WH, Parson WW, et al. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations. J Neurol Sci 2010; 296: 22-29.
43. Malfatti E, Olivé M, Taratuto AL, et al. Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders. J Neuropathol Exp Neurol 2013; 72: 833-845.
44. Sabatelli P, Castagnaro S, Tagliavini F, et al. Aggresome-autophagy involvement in a sarcopenic patient with rigid spine syndrome and a p.C150R mutation in FHL1 gene. Front Aging Neurosci 2014; 6: 215.
45. Gueneau L, Bertrand AT, Jais JP, et al. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2009; 85: 338-353.
46. Schreckenbach T, Henn W, Kress W, et al. Novel FHL1 mutation in a family with reducing body myopathy. Muscle Nerve 2013; 47: 1271-34.
47. Faulkner G, Lanfranchi G, Valle G. Telethonin and other new proteins of the Z-disc of skeletal muscle. IUBMB Life 2001; 51: 275-282.
48. Vorgerd M, van der Ven PF, Bruchertseifer V, et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 2005; 77: 297-304.
49. Kley RA, Hellenbroich Y, van der Ven PFM, et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain 2007; 130: 3250-3264.
50. Shatunov A, Olive M, Odgerel Z, et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet 2009; 17: 656-663.
51. Luan X, Hong D, Zhang W, Wang Z, Yuan Y. A novel heterozygous deletion-insertion mutation (2695-2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family. Neuromuscul Disord 2010; 20: 390-396.
52. Kley RA, Serdaroglu-Oflazer P, Leber Y, et al. Pathophysiology of protein aggregation and extended phenotyping in filaminopathy. Brain 2012; 135: 2642-3660.
53. Duff RM, Tay V, Hackman P, et al. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. Am J Hum Genet 2011; 88: 729-740.
54. Tasca G, Odgerel Z, Monforte M, et al. Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia. Muscle Nerve 2012; 46: 275-282.
55. Hauser MA, Horrigan SK, Salmikangas P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1 A. Hum Mol Genet 2000; 14: 2141-2147.
56. Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004; 62: 1363-1371.
57. Foroud TN, Pankratz AP, Batchman MW, et al. A mutation in myotilin causes spheroid body myopathy. Neurology 2005; 65: 1936-1940.
58. Olivé M, Goldfarb L, Shatunov A, et al. Myotilinopathy: refining the clinical and myopathological phenotype. Brain 2005; 128: 2315-2326.
59. Schessl J, Bach E, Rost S. Novel recessive myotilin mutation causes severe myofibrillar myopathy. Neurogenetics 2014; 15: 151-156.
60. Reilich P, Krause S, Schramm N, et al. A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A). J Neurol 2011; 258: 1437-1444.
61. Smith FJ, Eady RA, Leigh IM, et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet 1996; 13: 450-457.
62. Banwell BL, Russel J, Fukudome T, et al. Myopathy, myasthenic syndrome, and epidermolysis bullosa simplex due to plectin deficiency. J Neuropathol Exp Neurol 1999; 58: 832-846.
63. Gundesli H, Talim B, Korkusuz P, et al. Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy. Am J Hum Genet 2010; 87: 834-841.
64. Schröder R, Kunz WS, Rouan F, et al. Disorganization of the desmin cytoskeleton and mitochondrial dysfunction in plectin-related epidermolysis bullosa simplex with muscular dystrophy. J Neuropathol Exp Neurol 2002; 61: 520-530.
65. Chauveau C, Rowell J, Ferreiro A. A rising titan: TTN review and mutation update. Hum Mutat 2014; 35: 1046-1059.
66. Myhre JL, Pilgrim D. A Titan but not necessarily a ruler: assessing the role of titin during thick filament patterning and assembly. Anat Rec (Hoboken) 2014; 297: 1604-1614.
67. Ohlsson M, Hedberg C, Brådvik B, et al. Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. Brain 2012; 135: 1682-1694.
68. Carmignac V, Salih MAM, Quijano-Roy S, et al. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol 2007; 61: 340-351.
69. Ceyhan-Birsoy O, Agrawal PB, Hidalgo C, et al. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology 2013; 81: 1205-1214.
70. Palmio J, Evilä A, Chapon F, et al. Hereditary myopathy with early respiratory failure: occurrence in various populations. J Neurol Neurosurg Psychiatry 2014; 85: 345-353.
71. Lin X, Ruiz J, Bajraktari I, et al. Z-disc-associated, alternatively spliced, PDZ motif-containing protein (ZASP) mutations in the actin-binding domain cause disruption of skeletal muscle actin filaments in myofibrillar myopathy. J Biol Chem 2014; 289: 13615-13626.
72. Selcen D, Engel AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 2005; 57: 269-276.
73. Griggs R, Vihola A, Hackman P, et al. Zaspopathy in a large classic late-onset distal myopathy family. Brain 2007; 130: 1477-1484.
74. Cai H, Yabe I, Sato K, et al. Clinical, pathological, and genetic mutation analysis of sporadic inclusion body myositis in Japanese people. J Neurol 2012; 259: 1913-1922.
75. Joshi PR, Hauburger A, Kley R, et al. Mitochondrial abnormalities in myofibrillar myopathies. Clin Neuropathol 2014; 33: 134-142.